Gangliosides in human fetal brain. 1991

L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
Department of Psychiatry and Neurochemistry, University of Göteborg, Sweden.

The ganglioside concentration and composition were determined in 42 human fetal brains from gestational week 10 to 22, a period that is morphologically characterized by rapid neuroblast proliferation and migration. The ganglioside concentration was constant during this period, approximately 1 mumol of ganglioside sialic acid/g of fresh tissue weight. At gestational week 10 the ganglioside pattern was dominated by gangliosides of the ganglio b series, with the major ganglioside being GT1b, contributing 40% of total ganglioside sialic acid, whereas GD1b and GD3 contributed only 15 and 10%, respectively. The proportion of b series ganglioside decreased to gestational week 22, with the most pronounced relative reduction affecting GD3, but also GT1b and GD1b to a lesser extent. The ganglioside GQ1b increased in content from gestational week 10 and peaked around week 16. The proportion of GD1a increased markedly between gestational week 12 and 14 and slowly between week 14 and 18 and then increased rapidly from week 20. Ganglioside GM1 underwent a similar change. Gangliosides of the lacto series contributed 6-10% of ganglioside sialic acid between gestational week 10 and 15, and thereafter the proportion slowly decreased. 3'-isoLM1 decreased rapidly in content from gestational week 10 (20 nmol/g of fresh weight) to week 22 (less than 0.5 nmol/g of fresh weight), whereas the gangliosides of the neolacto series (3'-LM1 and 3',8'-LD1) showed a slower and less marked decline in level. The biological significance of the ganglioside changes is discussed.

UI MeSH Term Description Entries
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006028 Glycosphingolipids Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) Asialoganglioside,Asialogangliosides,Glycosphingolipid,Sphingoglycolipid,Sphingoglycolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
May 1970, Life sciences. Pt. 2: Biochemistry, general and molecular biology,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
May 1963, Life sciences (1962),
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
January 1976, Acta medica Iugoslavica,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
September 1963, Journal of neurochemistry,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
March 1956, Nature,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
March 1964, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
March 1985, Cancer research,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
April 1992, Neurochemistry international,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
September 1991, The International journal of developmental biology,
L Svennerholm, and B M Rynmark, and G Vilbergsson, and P Fredman, and J Gottfries, and J E Månsson, and A Percy
February 1992, Biochimica et biophysica acta,
Copied contents to your clipboard!